<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on May 29, 2018</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT02727569</url>
  </required_header>
  <id_info>
    <org_study_id>GART1046</org_study_id>
    <nct_id>NCT02727569</nct_id>
  </id_info>
  <brief_title>Quantification of Agreement and Variability of a Newly Developed Visual Field Algorithm With the Reference Standard</brief_title>
  <acronym>vFAST</acronym>
  <official_title>Quantification of Agreement and Variability Characteristics of a Newly Developed Visual Field Algorithm With the Reference Standard: an Observational Study</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Moorfields Eye Hospital NHS Foundation Trust</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>Moorfields Eye Hospital NHS Foundation Trust</source>
  <oversight_info>
    <has_dmc>No</has_dmc>
  </oversight_info>
  <brief_summary>
    <textblock>
      This study aims to compare two types of visual field test; retinal sensitivity values
      obtained with the reference standard Swedish Interactive Thresholding Algorithm (SITA) of the
      standard visual field test and with a newly developed test algorithm. The new test is a
      visual field test presented on a flat-panel monitor and has two modes: differential light
      sensitivity (DLS; equivalent to the standard visual field test) and the Moorfields Motion
      Displacement Test (MMDT). DLS sensitivity and DLS measurement variability will be determined
      and compared between the SITA algorithm of the standard visual field test and the new visual
      field test on the flat-panel monitor. The measurement variability of the MMDT will be
      quantified.

      The long-term goal is to reduce test variability below that observed in SITA by 20%, whilst
      producing comparable measurements (contrast threshold values) for comparable test duration.
    </textblock>
  </brief_summary>
  <detailed_description>
    <textblock>
      Standard Automated Perimetry (SAP) is currently the standard test for screening and
      monitoring visual loss owing to glaucoma. This test requires the patient to sit at a machine,
      looking at a central light and pressing a button whenever small spots of light appear in the
      peripheral vision. Traditionally these spots of light are projected into a bowl (concave
      surface), but more recently, computer monitors have been used. Other techniques are also now
      available such as the Moorfields Motion Displacement Test, where patients are required to
      press a button each time they see a vertical line on the screen wiggle. This test has been
      shown to have advantages over SAP, namely, to be tolerant to the effects of cataract and
      refractive error.

      In clinical settings, the Humphrey Visual Field Analyzer (Zeiss Meditec) is the most used
      visual field test in the UK. It employs a SAP strategy coupled with the Swedish Interactive
      Thresholding Algorithm (SITA), which is used to derive retinal sensitivity. Visual field
      measurements are very variable, requiring many tests over a long period to determine the
      extent of vision loss. In addition to the inconvenience caused to patients, the contribution
      of these many tests to the financial burden on the NHS is increasing with the growing aging
      population. As glaucoma is a chronic disease, patients need lifelong monitoring, requiring
      multiple tests and clinic visits. To address these unmet needs, the investigators have
      developed a new algorithm that can be used to monitor glaucoma.

      The investigators wish to carry out a study, which will allow them to compare agreement
      between SITA and a newly developed test algorithm. Measurement variability will be determined
      and compared between strategies. The long-term goal is to reduce test variability and the
      test time observed in SITA, whilst producing comparable contrast threshold values.
    </textblock>
  </detailed_description>
  <overall_status>Unknown status</overall_status>
  <last_known_status>Not yet recruiting</last_known_status>
  <start_date>April 2016</start_date>
  <completion_date type="Anticipated">September 2017</completion_date>
  <primary_completion_date type="Anticipated">August 2017</primary_completion_date>
  <study_type>Observational</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <observational_model>Cohort</observational_model>
    <time_perspective>Prospective</time_perspective>
  </study_design_info>
  <primary_outcome>
    <measure>To quantify the threshold difference in the test-retest variability of DLS obtained with the new algorithm and the SITA algorithm. To quantify the threshold test-retest variability of the MMDT with the new algorithm.</measure>
    <time_frame>Through study completion, an average of 1 year.</time_frame>
  </primary_outcome>
  <secondary_outcome>
    <measure>To quantify the difference in DLS thresholds measured with the new and SITA algorithms across all retinal locations and for a range of visual field sensitivities.</measure>
    <time_frame>Through study completion, an average of 1 year.</time_frame>
  </secondary_outcome>
  <secondary_outcome>
    <measure>To determine whether any differences in thresholds obtained on the two algorithms vary with retinal eccentricity and stimulus energy. Mean difference for each location will be reported in decibels.</measure>
    <time_frame>Through study completion, an average of 1 year.</time_frame>
  </secondary_outcome>
  <secondary_outcome>
    <measure>To determine whether any differences in test-retest variability obtained on the two algorithms vary with retinal eccentricity and stimulus energy. Mean difference between test-retest for each location will be reported in decibels.</measure>
    <time_frame>Through study completion, an average of 1 year.</time_frame>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Participants preference for a more reliable visual fields test or for having a shorter test (questionnaire).</measure>
    <time_frame>Through study completion, an average of 1 year.</time_frame>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Participants preference of test strategy, MMDT or DLS (questionnaire).</measure>
    <time_frame>Through study completion, an average of 1 year.</time_frame>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Participants preference of test algorithm, newly developed algorithms or the SITA algorithm (questionnaire).</measure>
    <time_frame>Through study completion, an average of 1 year.</time_frame>
  </secondary_outcome>
  <number_of_groups>2</number_of_groups>
  <enrollment type="Anticipated">110</enrollment>
  <condition>Glaucoma</condition>
  <condition>Healthy</condition>
  <arm_group>
    <arm_group_label>Feasibility Study</arm_group_label>
    <description>10 subjects. Subjects will performed two different versions of the new visual field algorithm with DLS (differential light sensitivity) strategies. Two repeats of each strategy will be performed.</description>
  </arm_group>
  <arm_group>
    <arm_group_label>Clinical evaluation study</arm_group_label>
    <description>100 subjects. Subjects will performed a visual field assessment with the new visual field algorithm with MMDT (Moorfields Motion Displacement Test) and DLS -like stimuli and a commercial available SITA algorithm (DLS-like strategy). Two repeats of each strategy will be performed.</description>
  </arm_group>
  <intervention>
    <intervention_type>Device</intervention_type>
    <intervention_name>New visual field algorithm with DLS</intervention_name>
    <description>Mathematical model (software based) to derive retinal sensitivity.</description>
    <arm_group_label>Feasibility Study</arm_group_label>
    <arm_group_label>Clinical evaluation study</arm_group_label>
  </intervention>
  <intervention>
    <intervention_type>Device</intervention_type>
    <intervention_name>SITA algorithm</intervention_name>
    <description>Mathematical model (software based) to derive retinal sensitivity. Commercially available.</description>
    <arm_group_label>Clinical evaluation study</arm_group_label>
  </intervention>
  <intervention>
    <intervention_type>Device</intervention_type>
    <intervention_name>New visual field algorithm with MMDT</intervention_name>
    <description>Mathematical model (software based) to derive retinal sensitivity.</description>
    <arm_group_label>Clinical evaluation study</arm_group_label>
  </intervention>
  <eligibility>
    <study_pop>
      <textblock>
        Participants will be recruited using three methods:

          1. The volunteer database of the Glaucoma Research Unit. Letters will be sent to
             patients/healthy controls, who in the past agreed to be contacted for research
             purposes. Written information about the project will be sent with the letters.

          2. Records screening. Patients' records will be screened in advance or during their
             clinical appointment. Persons identified as meeting the inclusion criteria will be
             invited to join the study, whereupon written information about the project will be
             given to the patient. Patients will be invited to join the study by letter, prior to
             their clinical appointment or in person on the day of the appointment.

          3. Invitation of accompanying persons and staff. It is anticipated that spouses and
             acquaintances of existing subjects, as well as staff at the research site, Moorfields
             Eye Hospital and UCL Institute of Ophthalmology, may offer their participation as
             healthy volunteers.
      </textblock>
    </study_pop>
    <sampling_method>Non-Probability Sample</sampling_method>
    <criteria>
      <textblock>
        Inclusion Criteria:

          -  Best corrected visual acuity of 6/12 or better in the test eye

          -  No ocular morbidity other than glaucoma; early lens opacity and prior cataract surgery
             are acceptable

        Healthy eyes

          -  Central 30Â° visual field within normal limits on the 24-2 test (MD within 95 % CI and
             glaucoma hemifield test within normal limits).

        Glaucoma eyes

          -  More than two reliable visual fields with reproducible defects

          -  IOP &lt; 30 mmHg

        Exclusion Criteria:

          -  Any systemic disease which is likely to affect visual performance in a short period of
             time

          -  Inability to steadily fixate on the test (e.g. individuals who have nystagmus or
             macular degeneration)

          -  Eyes with unreliable visual fields (defined as false positive responses &gt;15%)
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>18 Years</minimum_age>
    <maximum_age>100 Years</maximum_age>
    <healthy_volunteers>Accepts Healthy Volunteers</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>David Garway-Heath, MD</last_name>
    <role>Principal Investigator</role>
    <affiliation>NIHR Biomedical Research Centre, Moorfields Eye Hospital and UCL Institute of Ophthalmology</affiliation>
  </overall_official>
  <overall_contact>
    <last_name>Marco Miranda, PhD</last_name>
    <email>marco.miranda@moorfields.nhs.uk</email>
  </overall_contact>
  <location>
    <facility>
      <name>Moorfields Eye Hospital</name>
      <address>
        <city>London</city>
        <zip>EC1V 2PD</zip>
        <country>United Kingdom</country>
      </address>
    </facility>
  </location>
  <location_countries>
    <country>United Kingdom</country>
  </location_countries>
  <verification_date>March 2016</verification_date>
  <!-- For several months we've had both old and new date name tags                             -->
  <!-- Now, the old date names have been dropped.                                               -->
  <!-- The new date name replacements are:                                                      -->
  <!--     OLD (gone)                                        NEW (in use)                       -->
  <!--   lastchanged_date                         becomes   last_update_submitted               -->
  <!--   firstreceived_date                       becomes   study_first_submitted               -->
  <!--   firstreceived_results_date               becomes   results_first_submitted             -->
  <!--   firstreceived_results_disposition_date   becomes   disposition_first_submitted         -->
  <study_first_submitted>March 15, 2016</study_first_submitted>
  <study_first_submitted_qc>March 29, 2016</study_first_submitted_qc>
  <study_first_posted type="Estimate">April 4, 2016</study_first_posted>
  <last_update_submitted>March 29, 2016</last_update_submitted>
  <last_update_submitted_qc>March 29, 2016</last_update_submitted_qc>
  <last_update_posted type="Estimate">April 4, 2016</last_update_posted>
  <responsible_party>
    <responsible_party_type>Sponsor</responsible_party_type>
  </responsible_party>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

